Dr G. Nicolaes, Cardiovascular Research Institute Maastricht, CARIM, Maastricht University, the Netherlands

Dr B. Deprez, Inserm U1177 – Lille2 University (IFR114) – Pasteur Institute Lille (IFR142), France, Medicinal chemistry

Dr N. Bonnefoy, Inserm U896, Montpellier1, France, cancer and immunity

Dr. K. Majid, Inserm U1029, University Bordeaux 1 France, cancer research

Dr. M. Reboud, Univ Paris 6, Paris France, cancer research

Dr. E. Ogier-Denis, Medical Faculty Xavier Bichat France, Inserm U773-CRB3, rare disease

Dr. P. Dariavach, UMR 5160 CNRS, Montpellier, France, immunity and cancer

Dr. B. Dahlback, Malmo Hospital/Lund University, Sweden, cardiovascular disease

Dr. J. Vidal, Univ Rennes 1, France, medicinal chemistry - cancer

Dr. M. Alvarado-Kristensson, Malmo Hospital/Lund University, Sweden, Cancer

Dr. A. Blom, Malmo Hospital/Lund University, Sweden, Complement system

Dr. J. Fernandez-Recio, Bacelona, Spain, protein-protein interactions

Dr. JL. Poyet, Hospital Saint-Louis, Paris, Cancer

Dr. H. Bruzzoni-Giovanelli, Hospital Saint-Louis, Paris, Cancer

Dr. F. Leroux, Inserm U1177 – Lille2 University (IFR114) – Pasteur Institute Lille (IFR142), France, Medicinal chemistry

Dr. D. Eladari, Inserm - European Hospital Paris, Cardiovascular diseases

Dr. J. Teulon, Univ Paris 6, Cardiovascular diseases

Dr. R. Rimokh and Dr. G. Gillet, Lyon Cancer Institute, Cancer

Dr. J. Weitzman, Univ Paris 7, Cancer, Epigenetics

Dr. V Fremeaux-Bacchi - European Hospital Paris, Complement system

Dr. L Roumenina, Inserm Paris, Complement system